This webinar will be hosted readily available and live on-demandThursday, September 21, 2023 11:30 AM Eastern Time Vaccines deal researchers and clinicians the ability to boost or modulate the body immune system, which carries unique guarantee for cancer treatment. Whether targeting the fundamental tumor-killing capabilities of immune cells or improving effectiveness of established immunotherapies, researchers work towards restorative vaccines that enhance the anticancer immune system.In this webinar brought to you by The Scientist, Denise Cecil and James Gulley will share brand-new progress in the cancer vaccine field. They will highlight the clinical rationale behind these preventatives, discuss which cancers are the primary targets, and discuss the main obstacles to cancer vaccine implementation.Topics to be covered The function that therapeutic vaccines play when combined with immunotherapy The newest medical trial information on healing vaccines for multiple forms of cancerDenise Cecil, PhD Principal ScientistCancer Vaccine InstituteUniversity of WashingtonJames L. Gulley, MD, PhD Senior InvestigatorCo-Director, Center for Immuno-OncologyDeputy Director, Center for Cancer Research Clinical Director, National Cancer InstituteSponsored by
